The Valley Desk

NCT06541704 · Interventional trial

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Overall registry status Recruiting

Phase 3

Conditions Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov